Dermapharm Holding SE (LON:0A5J)

Market Cap	1.74B
Revenue (ttm)	988.61M
Net Income (ttm)	94.10M
Shares Out	n/a
EPS (ttm)	1.75
PE Ratio	18.49
Forward PE	n/a
Dividend	0.75 (1.96%)
Ex-Dividend Date	Jun 27, 2025

Volume	29,445
Average Volume	22,496
Open	38.13
Previous Close	38.80
Day's Range	37.95 - 38.35
52-Week Range	24.97 - 35.50
Beta	n/a
RSI	52.76
Earnings Date	May 15, 2025

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as product...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,610
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5J

Financial Performance

In 2024, Dermapharm Holding SE's revenue was 1.20 billion, an increase of 3.89% compared to the previous year's 1.15 billion. Earnings were 113.79 million, an increase of 82.44%.

Financial numbers in EUR